Concepedia

Matthew Hickey

MH

Statistics

Publications

11

Citations

884

H-Index

10

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

GlaxoSmithKline (United Kingdom)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Eli Lilly (United States)

AstraZeneca (United Kingdom)

Matthew Hickey is an author at Bristol-Myers Squibb (United States) specializing in natural sciences, chemistry, and organic chemistry.

Publications per year

2000–2023

11

Publications

11

Key Green Chemistry research areas from a pharmaceutical manufacturers’ perspective revisited

Marian C. Bryan, Peter J. Dunn, David A. Entwistle et al. · Green Chemistry · 2018 · 601 citations · Full text

, , +17

TCFH–NMI: Direct Access to <i>N</i>-Acyl Imidazoliums for Challenging Amide Bond Formations

Gregory L. Beutner, Ian S. Young, Merrill L. Davies et al. · Organic Letters · 2018 · 142 citations · Full text

, , +6

Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor

Kenneth J. Fraunhoffer, Albert J. DelMonte, Gregory L. Beutner et al. · Organic Process Research & Development · 2019 · 38 citations

, , +10

Beyond Amide Bond Formation: TCFH as a Reagent for Esterification

Nathaniel R. Luis, Kasey K. Chung, Matthew Hickey et al. · Organic Letters · 2023 · 22 citations

, , +7

Process Development and Pilot Plant Synthesis of Methyl 2-Bromo-6-chlorobenzoate

Matthew Hickey, Shawn P. Allwein, Todd D. Nelson et al. · Organic Process Research & Development · 2005 · 16 citations

, , +9

1–5 of 11